Sachs David C. (CIK 1848899) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-24). Recent activity: Buy IBRX (40,650 shares), Sell IBRX (20,682 shares), Buy IBRX (82,236 shares), Sell IBRX (42,643 shares), Buy IBRX (30,397 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Buy | 40,650 | $0 |
| 2026-02-24 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Sell | 20,682 | $179,933 |
| 2026-02-12 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Buy | 82,236 | $0 |
| 2026-02-12 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Sell | 42,643 | $295,516 |
| 2026-01-05 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Buy | 30,397 | $0 |
| 2026-01-05 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Sell | 15,435 | $30,561 |
| 2025-02-25 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Buy | 40,650 | $0 |
| 2025-02-25 | ImmunityBio, Inc. (IBRX) | Chief Financial Officer | Sell | 15,860 | $54,241 |
Source: SEC Form 4 filings · as of 2026-02-24